2000

Dansk Selskab for Cancerforsknings 13. årsmøde
Fredag 5. maj 2000 kl. 9.00 - 17.30 på Vilvorde KursusCenter Mødet arrangeres i samarbejde med Medicon Valley Academy.
Program for årsmødet
08.00-09.00 09.00-09.05	Registrering, opsætning af posters og kaffe Velkomst ved Selskabets formand, Paul E.G. Kristjansen Praktiske oplysninger ved Selskabets sekretær, Jørgen H. Olsen
SESSION I: Tumor biology Chairmen: Nils Brünner, Berthe M.Willumsen
09.05-9.15	Cloning of a novel urokinase receptor-associated membrane protein Engelholm LH, Jensen ON, Mørtz E, Mann M, Danø K, Behrendt N
09.20-9.30	MTS1 (S100A4) modulates the transcriptional activity of tumor suppressor P53 protein Kruse CE, Christensen A, Cohn MA, Lukanidin E, Grigorian M
09.35-9.45	Rapid destruction of human CDC25A phosphatase defines a novel G1/S checkpoint response to DNA damage Mailand N, Falck J, Lukas C, Syljuåsen R, Bartek J, Lukas J
09.50-10.35	BRISTOL-MYERS SQUIBB LECTURE: Drug Resistance in Cancer Susan E, Bates, MD, Medicine Branch, NCI, USA
10.35-11.25	POSTERS og kaffe
SESSION II: Lung Cancer Chairmen: Jens Benn Sørensen, Torben Skovsgård
11.25-11.35	Non-angiogenic alveolar microvessel pattern in non-small-cell lung carcinoma: A new prognostic indicator Offersen BV, Pfeiffer P, Hamilton-Dutoit S, Overgaard J
11.40-11.50	Characterisation of gene expression caused by the type III epidermal growth factor receptor mutation Pedersen MW, Andersen TT, Ørntoft TF, Poulsen HS
11.55-12.05	Four out of six human NYH small cell lung cancer cell lines resistant to ICRF-187 have either R162Q or Y165S functional mutations in the Walker ATP binding site of topoisomerase lia Wessel I, Jensen LH, Nitiss JL, Jensen PB, Sehested M
12.10-12.20	Uddeling af gårdejer Ingemann Petersen og Hustrus Fond som Dansk Selskab for Cancerforsknings hæderspris.
12.20-13.40	Frokost
SESSION III: Molecular targets for diagnosis and treatment Chairmen: Michael R. Horsman, Peter Andreasen
13.40-13.50	Genetic analysis of the role of plasminogen activation in murine tumor metastasis Almholt K, Lund LR, Johnsen M
13.55-14.05	Expression of hyaluronidases in small cell lung cancer (SCLC) and glioma in vitro and in vivo Junker N, Petersen LN, Kristjansen PEG
14.10-14.20	Inhibition of matrix metalloproteinases increases survival of mice with bone metastases of human breast cancer Winding B, Therkildsen B, Jakobsen M, Sveigaard C, Misander H
SESSION IV: Clinical correlates Chairmen: Kell Østerlind, Claus A. Kristensen
14.25-14.35	The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism Sørensen HT, Mellemkjær L, Steffensen FH, Olsen JH, Nielsen GL
14.40-14.50	Prognostic model for node negative breast cancer patients from flow cytometric DNA histograms Bruce Bagwell C, Bendahl P-O, Stål O, Falkmer U, Killander D, Baldetorp B
14.55-15.05	Characterization of the new, multidrug resistance protein MXR Litman T, Brangi M, Hudson E, Resau JH, Skovsgaard T, Bates SE
15.10-16.00	POSTERS og kaffe
SESSION V: Hereditary cancer Chairmen: Lone Nørgård Petersen, Torben Kruse
16.00-16.10	Analysis of protein interactions in human DNA mismatch repair complexes Jäger AC, Rasmussen M, Bisgaard HC, Nielsen FC, and Rasmussen LJ
16.15-16.25	Identifying novel breast cancer predisposing genes Vallon-Christensen J, Hedenfalk I, Duggan D, Loman N, Johannsson O, Olsson H, Peterson C, Kallioniemi O-P, Trent J, Borg Å
16.30-16.40	Risk of cancer among siblings of childhood cancer patients: A collaborative study in the Nordic countries Winther JF, Sankila R, Tulinius H, Barlow L, Glattre E, Langmark F, Möller T, Olafsdottir GH, Ritvanen A, Olsen JH
16.45-17.00	Pause med øl/vand
17.00-17.10	Uddeling af pris for bedste foredrag
17.10-17.20	Uddeling af pris for bedste posterpræsentation
18.30	Festmiddag